Dr. Tian Wenzhi

Chairman of the Board, Chief Executive Officer, Chief Scientific Officer

    Dr. Tian Wenzhi, founded the company in June 2015, serving as the chairman of the Board, the chief executive officer and the chief scientific officer. Dr. Tian is responsible for the overall strategic planning, business management, and innovative research and development.

    Dr. Tian has over 30 years of experience in the biomedical industry. Dr. Tian worked on immunology research at Weill Cornell Medical College and North Shore University Hospital in the United States for several years. He later served as a principal research associate at ImClone Systems (acquired by Eli Lilly and Company), where he was responsible for research of monoclonal antibody drugs addressing novel tumor targets. Dr. Tian co-founded Huabo Biopharm and served as its general manager. Dr. Tian has published 32 scientific papers and owns 12 issued patents. Dr. Tian has published 32 scientific papers and owns 12 issued patents.